(Reuters) - Catalent said on Wednesday its stockholders have voted to approve Novo Nordisk parent's $16.5 billion bid to take over the contract manufacturer. In February, Novo Holdings had agreed to buy Catalent, a key manufacturing subcontractor o.
J&J scoops up another atopic dermatitis drug for $1.25B fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Lilly to pour $5B more into expanding Zepbound, Mounjaro production biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.